newsfilter
← Latest News
Business Wire·

Verastem Oncology to Present at Upcoming Investor Conferences

Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to participate